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ABSTRACT
Experimental cell or ex vivo gene therapy for localized bone formation typically uses osteo-
progenitor cells propagated from periosteum or bone marrow. Both require bone or mar-
row biopsies to obtain cells. We have demonstrated that implantation of gingival or dermal
fibroblasts transduced with BMP ex vivo, using a recombinant adenovirus (AdCMVBMP)
attached to porous biodegradable scaffolds, form bone in vivo. Here we show that BMP-7-
transduced fibroblasts suspended in injectable thermoset hydrogels form complete ossicles
on subcutaneous injection and repair segmental defects in rat femurs. Bone formation was
preceded by an intermediate cartilage stage. To determine the fate of the implanted trans-
duced cells, thermoset hydrogel suspensions of ex vivo BMP-7-transduced or nontransduced
fibroblasts were placed in diffusion chambers and implanted to allow development in vivo
without direct contact with host cells. Only the BMP-transduced fibroblasts formed bone
within the diffusion chambers in vivo, revealing that BMP transduction induces osteoblas-
tic conversion of these cells.
INTRODUCTION
CELL THERAPY, one current approach to tissue engineering, may be utilized for the restoration of con-genital or acquired loss of tissue structure and function. In a combination of cell and gene therapy,
known as ex vivo gene therapy,1 the cells to be implanted are removed from the patient and genetically al-
tered before implantation in vivo. The genetically altered cells have typically been fibroblasts or myoblasts
that are easily biopsied and propagated in vitro.2 Genetic alteration may be accomplished with recombinant
plasmid or viral vectors.
Osteoprogenitor cells such as those derived from bone marrow cultures or periosteum form bone on im-
plantation in vivo without(3,4) or with ex vivo genetic modification.5–13 However, this approach requires that
bone or bone marrow be biopsied; a procedure often associated with substantial donor site morbidity. Ob-
taining cells for autologous grafts from easily biopsied, readily regenerating tissues such as skin or gingiva
would likely be associated with less morbidity. Therefore we have utilized ex vivo gene therapy to test the
idea that autologous cells for tissue regeneration need not be obtained from the tissue to be regenerated.14
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This approach was suggested by the well-documented capacity of recombinant human bone morphogenetic
proteins (BMP) to induce endochondral-like bone formation on implantation into dermis, muscle,15,16 or gin-
giva (R.B. Rutherford, unpublished observations) and the evidence that local cells initiate healing responses
(reviewed by Prokop17). These observations suggest that several tissue types contain populations of cells re-
sponsive to the inductive effects of BMP. We have demonstrated that cultured nonimmortal strains of gin-
gival or dermal fibroblasts, transduced ex vivo by the mouse BMP-7 full-length cDNA, secrete biologically
active BMP-7 in vitro, and when absorbed to porous, preformed sponges and implanted in vivo, induce ec-
topic and orthotopic bone formation. Both the implanted donor and host cells participate in the bone forma-
tion, resulting in chimeric ossicles comprising both donor and host-derived extracellular matrix.14 These data
suggested that the BMP-transduced fibroblasts in contact with host tissue converted to osteoblasts in vivo.
The use of BMP-transduced fibroblasts that contribute to bony matrix production as well as induce host
tissues to produce bone could be advantageous in clinical conditions characterized by relatively large acel-
lular lesions such as those produced by surgical resection of tumors and radiation therapy. Our hypothesis
is that BMP-responsive fibroblasts may be propagated from skin and gingiva ex vivo and stimulated to form
predetermined amounts of bone on implantation in vivo. Here we report that BMP-transduced fibroblasts
suspended in thermoset hydrogels from cartilage that converts to marrow-containing ectopic ossicles in vivo.
The size of these ectopic ossicles varies with the number of cells injected. Such preparations absorbed to
preformed porous sponges also induce repair of femoral segmental defects. In addition, BMP-transduced
fibroblasts suspended in a hydrogel form bone in vivo in the absence of direct contact with host tissue.
These data reveal that BMP-7 transduction induces an osteoblastic conversion of nonosteoblastic fibroblasts
that is not dependent on direct interaction of the transduced cells with host tissue.
MATERIALS AND METHODS
Materials
All reagents were purchased from Sigma (St. Louis, MO) or GIBCO-BRL (Grand Island, NY) unless
otherwise noted. Defined fetal bovine sera were obtained from HyClone (Provo, UT). Gelfoam was ob-
tained from Upjohn (Kalamazoo, MI) and tissue culture ware was obtained from Corning (Corning, NY).
NIH-bg-nu-xid br (NIH III) and C57BL/6 mice were purchased from Charles River (Wilmington, MA).
BMP transduction and preparation of cell–hydrogel suspensions
Human gingival (HGF), C57BL/6 mouse dermal (MDF), or Fischer rat (RDF) fibroblastic cell strains were
derived from explants of tissue biopsies and cultured as described.18 Cells from passage 3–12 were removed
from liquid nitrogen storage and grown to near confluence in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum, penicillin, and streptomycin. HGF infection with AdRSVlacZ or
with AdCMVBMP-2, -4, or -719 was at a multiplicity of infection (MOI) of 200 PFU/cell whereas MDF and
RDF infection was at 1000 PFU/cell. Cells, confluent in 75-cm2 flasks, were exposed to the appropriate di-
lution of virus in 8 ml of medium for 24 h at 37°C in a humidified atmosphere of 5% CO2 before trypsiniza-
tion, counting, and resuspension in the appropriate hydrogel at the desired concentration. Matrigel (growth
factor reduced; Collaborative Biomedical Products, Bedford, MA) and acid-soluble rat tail collagen solution
(final concentration, 2.5 mg/mL; Collaborative Biomedical Products) were prepared according to the manu-
facturer directions. Pluronic F127 (BASF, Mt. Olive, NJ) was mixed in sterile distilled water to a final con-
centration of 30%. All these materials are thermoset hydrogels at the concentrations used: liquids at 4°C that
gel as the temperature approaches 37°C. The mass of ossicles was determined by wet weight and the data
were analyzed by analysis of variance (ANOVA) and post-hoc analysis for significance with the Scheffe F
test. The student t test for paired samples was also used where appropriate.
Implantation of transduced cells and tissue analysis
Transduced cells were transplanted via subcutaneous injection of 200 mL of the indicated number of cells
in the backs of anesthetized NIH III mice for HGFs, or of C57BL/6 mice for MDFs. For the injections, a 26-
RUTHERFORD ET AL.
442
gauge hypodermic needle was used. The C57BL/6 cells and host animals are syngeneic, hence this system
models autologous transplantation into an immunocompetent host. For diffusion chamber experiments, 30 mL
containing a 105 BMP-7-transduced or nontransduced HGF–collagen suspension was injected into 4-mm-di-
ameter chambers prepared in sterilized 14 3 2 mm custom plastic disks and sealed with nitrocellulose mem-
branes (0.45 mm; Millipore, Bedford, MA). The sealed diffusion chambers were implanted subcutaneously.
For orthotopic assays of bone formation, Fisher rats were anesthetized with isoflurane and the hindlimbs
were aseptically prepared with Betadine and alcohol. The femurs were surgically exposed and a custom
drill template was used to drill and insert four fixation pins into the femur. An external fixator with a cen-
tral hinge, locked in a neutral position, was secured on the pins. A transverse simple 2- to 3-mm osteotomy
was created midway between the central two fixator pins with a micro-oscillating saw. The BMP-7-
transduced RDF–collagen construct was inserted into the osteotomy site and the soft tissues were closed.
BMP-7-transduced RDF–collagen construct comprised 104 cells suspended in type I collagen hydrogel (2.5
mg/mL, final concentration) and absorbed to moistened and flattened precut Gelfoam sponges. Control con-
structs contained 106 lacZ-transduced RDF.
After the indicated developmental interval in vivo, the tissues were harvested and fixed in fresh 4% para-
formaldehyde, demineralized in 10% formic acid, and processed for histological or immunocytochemical
analysis. Immunocytochemical analysis for BMP-7 expression was performed according to the Vectastain
ABC kit protocol (Vector Laboratories, Burlingame, CA). BMP-7 ligand and antibody were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). For calcium analysis, the ossicles were blotted dry after har-
vest, weighed, and incubated at 400°C for at least 8 h. The ash was weighed and analyzed for calcium con-
tent according to the manufacturers specifications (kit 587A; Sigma). The photomicrographs taken with a
digital camera were altered for brightness and contrast only in Adobe Photoshop (version 5.0). All proce-
dures using animals were performed under protocols approved by the University of Michigan Committee
on the Use and Care of Animals.
RESULTS
Ectopic ossicle formation by injected BMP-transduced fibroblast–hydrogel suspensions
Human gingival fibroblasts (HGFs), transduced ex vivo with a recombinant adenovirus containing the
full-length mouse BMP-7 cDNA,19 formed marrow-containing ossicles in vivo when suspended in acid-
soluble type I collagen and injected subcutaneously (Fig. 1). All ossicles produced by injecting BMP-2, -
4, or -7-transduced HGFs revealed a similar histological structure (Fig. 1A,B). However, nontransduced
HGFs, or HGFs transduced with bacterial lacZ, failed to form ossicles (Fig. 1C) and consistently produced
identifiable tissue masses only after large numbers of cells were implanted.
The mass of the ossicles varied with the number of BMP-7-transduced HGFs injected when suspended
in any of three distinct types of thermoset hydrogel (Table 1). Matrigel is a mixture of type IV collagen,
laminin, and trace amounts of growth factors. The type I collagen is an acid-soluble fraction extracted from
rat tails and Pluronic F127 is a surfactant with the common chemical name polyethylene-polyoxypropylene
block copolymer previously demonstrated to be effective as a cell delivery vehicle.20 Increasing the num-
ber of cells (103 to 2 3 106) injected in a constant volume of hydrogel (200 mL) yielded larger ossicles in
both immunodeficient and immunocompetent hosts (Table 1). As few as 103 and 104 BMP-transduced cells
suspended in Matrigel or collagen, respectively, formed complete ectopic ossicles (Fig. 1 and Table 1) on
subcutaneous injection. The mass of the ossicles produced by equal numbers of cells was greatest in Ma-
trigel (Table 1). All ossicles, regardless of hydrogel carrier or cell number injected, were composed of cor-
tical and medullary bone and contained marrow (Fig. 1). The calcium content of the ossicles produced by
BMP-7-transduced HGFs suspended in collagen increased with increasing numbers of implanted transduced
cells and was significantly higher than tissue formed in lacZ-transduced cell implants (Fig. 2).
BMP-transduced fibroblasts induce cartilage and bone
Implantation of exogenous BMP induces an endochondral-like bone formation process.21 To determine
whether ossicles produced by BMP-7-transduced fibroblasts follow a similar developmental pathway, in-
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duced tissues were harvested at various intervals and histological specimens were prepared. Histochemical
analyses of tissues produced by subcutaneous injection of 5 3 105 C57BL/6 fibroblasts into syngeneic hosts
reveal that cartilage precedes bone (n 5 4/4; Fig. 3). After 3 days, a condensation of cells is present (Fig.
3A) that matures to cartilage by 5–7 days (Fig. 3B) and to bone by 14 days (Fig. 3C). The cartilage phe-
notype is confirmed by the presence of cartilage extracellular matrix proteoglycans as detected by Safranin
O staining after 6 days in vivo (Fig. 3B). By 14 days developing marrow is evident (Fig. 3C, arrow).
Skeletal defect repair
To determine whether BMP-7-transduced HGFs suspended in collagen hydrogels induce local skeletal re-
generation, surgical osteotomies were prepared in rat femurs and implanted with BMP-7- or lacZ-transduced
syngeneic rat dermal fibroblasts (RDFs). In these experiments, 104 BMP-7- or 106 lacZ-transduced RDFs
suspended in a collagen hydrogel and absorbed into gelatin sponges were delivered to the respective sites.
lacZ-transduced RDFs failed to form bone bridging the defect (n 5 3/3; Fig. 4A,C,E). In contrast, BMP-7-
transduced RDFs induced cartilage and bone formation within the surgical defect within 6 weeks (n 5 3/3;
Fig. 4B,D,F). The regenerating bone fused with the existing fragments so that the cut ends are not evident
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FIG. 1. BMP-transduced fibroblasts suspended in a collagen thermoset hydrogel form ectopic marrow-containing os-
sicles in vivo. BMP-7-transduced (A, B) or nontransduced (C) HGFs were suspended in soluble thermoset collagen hy-
drogel (2.5 mg/ml, final concentration), injected subcutaneously into NIH III mice, harvested after 3 weeks, and ana-
lyzed histologically. (A) Histomicrograph of a typical ossicle formed with BMP-7-transduced HGFs suspended at 104
cells/200 mL of collagen; original magnification, 310. (B) Higher power magnification of sample in (A), demonstrating
bony trabeculae (b) and marrow (m); original magnification, 350; (C) histomicrograph of tissue produced by injection










































































































































































































































































































































































































































































































































































































































































































in the histological specimen (Fig. 4B,D). In the lacZ-transduced RDF control experiments, the defect con-
tained fibrous connective tissue with bone formation limited to remodeling the free ends of the bony frag-
ments.
Osteoblastic transformation of transduced fibroblasts
Our previous data demonstrated that the BMP-transduced fibroblasts as well as the host fibroblasts con-
tributed to the bony matrix,14 suggesting that the BMP-7-transduced fibroblasts converted to osteoblasts in
vivo. The ossicles formed by transduced fibroblasts developed through a cartilage intermediate that was
usually replaced with bone and marrow by 2–3 weeks (Fig. 3). To demonstrate that implanted cells directly
produce cartilage matrix, HGFs cotransduced with lacZ and BMP-7 were injected subcutaneously and the
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FIG. 2. Calcium content of collagen-suspended, BMP-7-transduced HGF-induced ossicles increases with increasing num-
bers of implanted cells. No identifiable implanted tissues were recovered from control sites containing fewer than 2 3 106
cells. Calcium content was measured from ashed samples by colorimetric assay according to the manufacturer instructions
(Sigma). Data represent means 6 standard deviation (n 5 3, representative of triplicate experiments). Calcium content of
samples from 2 3 106 cells is significantly different from control (*p , 0.01, Student t test for paired samples).
FIG. 3. BMP-7-transduced fibroblasts induce bone via an endochondral-like process in vivo. BMP-7-transduced
C57BL/6 dermal fibroblasts (5 3 105) suspended in type I collagen thermoset hydrogel (2.5 mg/mL, final concentra-
tion) were injected subcutaneously into C57BL/6 mice and the resulting tissue was harvested after 3 days (A), 6 days
(B), and 14 days (C). (A, C) Stained with H&E; (B) stained with Safranin O, which stains cartilage proteoglycans red.
Developing marrow is evident by 14 days (arrow, C), concomitant with the conversion of the cartilage to a bony ma-
trix. Original magnification, 3100.
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FIG. 4. BMP-7-transduced syngeneic dermal fibroblasts induce skeletal regeneration. Fischer rat dermal fibroblasts
were transduced with lacZ (A, B; n 5 3) or BMP-7 (C, D; n 5 3) and suspended at 106 or 104 cells/30 mL of colla-
gen hydrogel, respectively, absorbed to 5 3 5 3 5 mm pieces of gelatin sponge, and implanted into 3-mm surgical os-
teotomies in Fischer rat femurs for 6 weeks. Histologic analyses revealed only fibrous connective tissue forming in os-
teotomies implanted with lacZ-transduced RDFs (A, C; arrowheads mark bony margins); whereas bone (arrowheads)
and cartilage (double arrow) formed in lesions implanted with BMP-7-transduced RDFs (B, D). Radiographs of lacZ
control (E) and BMP-7-transduced (F) treated bones were taken after 6 weeks, just before sacrifice. Original magnifi-
cation: (A, B) 310; (C, D) 350.
resultant tissue was analyzed after 7 days. BMP-7- and LacZ-producing cells are directly associated with
and surrounded by the developing matrix (Fig. 5A,B) during the cartilagenous phase. These observations
reinforce our previously reported data,14 that ex vivo BMP-transduced fibroblasts directly contribute to ex-
tracellular matrix production. As a definitive test to demonstrate the osteoblastic conversion of fibroblasts
by ruling out a contribution by host cells, BMP-7-transduced HGF–collagen suspensions were sealed within
diffusion chambers and implanted subcutaneously. A mineralized matrix formed within sealed diffusion
chambers containing BMP-7-transduced HGF–collagen composites but not nontransduced fibroblast–
collagen composites within 6 weeks (n 5 9, six positive; Fig. 6A–C). Similar tissues were obtained from
chambers containing control nontransduced neonatal mouse calvarial-derived periosteal cells (Fig. 6D). The
host dermis was in close contact with the diffusion chamber at harvest, with little to no inflammation evi-
dent. Extensive histologic analysis of the tissue formed within the chambers (Fig. 5A,C) failed to detect
any evidence of host tissue contamination. In striking contrast to results obtained with injection of HGF–
hydrogel composites (Figs. 2 and 4), no evidence of angiogenesis or marrow formation was evident in the
tissues harvested from the diffusion chambers.
DISCUSSION
Among the pleiotropic effects of BMPs is their remarkable capacity to induce endochondral-like bone
formation in nonosteogenic tissues such as gingiva (R.B. Rutherford, unpublished observations), skin, or
muscle (reviewed by Kingsley15 and Reddi21,22). Our data reveal that osteogenesis induced by ex vivo BMP-
transduced fibroblasts follows a similar endochondral-like process (Figs. 3–5). The cartilage phase was com-
pletely converted to bone even though the rate of conversion appeared to vary with the number of cells im-
planted and the site of injection (i.e., ectopic vs. orthotopic) (Figs. 3 and 4). However, an organized
cartilage–bone interface resembling a growth plate was not detected in any of the several hundred sections
examined. These observations reveal that secreted and exogenous recombinant BMP-7 induces bone for-
mation by similar pathways.
One of the major challenges for the tissue engineering of bone is to regulate the amount and form of the
new tissue. In our earlier studies, using BMP-transduced fibroblasts and preformed scaffolds, the volume
of the ectopic ossicles was largely limited to the volume of the scaffold implanted, and did not vary sub-
stantially with the number of attached cells.14 Hence the resulting ossicle resembled the size and shape of,
and replaced, the implanted cell-laden scaffold. Although robust in producing bone that mimicks a pre-
formed shape, this approach is limited with regard to its ability to deliver osteogenic cells to lesions with
complicated anatomy. In the current study, we demonstrate that BMP-7-transduced fibroblasts suspended
in thermoset hydrogels from bone in vivo. In this ectopic bone induction assay, the size of the ossicle var-
ied with the number of BMP-7-transduced human cells injected subcutaneously and conformed to the shape
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FIG. 5. Ex vivo-transduced fibroblasts are associated with cartilage-like matrix. BMP-7- and lacZ-cotransduced HGFs
were suspended in a soluble collagen hydrogel (2.5 mg/mL, final concentration), injected subcutaneously into NIH III
mice, harvested after 7 days, and processed for histochemical and immunocytochemical analyses. (A) LacZ expression
by chondroblast-like cells; arrowheads indicate LacZ-producing cells. (B) BMP-7 expression by chondroblast-like cells.
(C) Specificity control section [for (B)] developed with anti-BMP-7 antiserum preincubated with BMP-7 ligand. Orig-
inal magnification: 3100.
of the tissue pouch created by injection (data not shown). The size was also dependent on the carrier used
but not the immunological competence of the host (Table 1). Hence the type of hydrogel carrier is likely
an important factor, because equal numbers of transduced HGFs in equal volumes of hydrogel produce dif-
ferent-sized ossicles depending on the hydrogel used (Table 1). The basis for this differential response has
not been studied. The materials tested vary widely in composition and have diverse uses. Matrigel is pro-
duced by tumor cells in vitro and contains several extracellular matrix molecules including nonfibrillar type
IV collagen and laminin.23 The type I collagen contains several cell-binding domains whereas Pluronic, a
synthetic surfactant, likely does not. Integrin-mediated cell–extracellular collagen interactions are impor-
tant in osteoblast differentiation.24–26 It is clear that, with fewer than 2 million cells, a carrier is necessary
for bone formation (Fig. 2 and Table 1). However, when more than 2 million cells suspended in culture
medium are injected, small ossicles develop (n 5 4/4; data not shown). The biologic basis for this matrix
effect is under investigation.
The use of either porous solid scaffolds or hydrogels alone as carriers for cell implants is not readily
adaptable to all potential clinical applications. For example, cells suspended in culture medium are readily
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FIG. 6. BMP-7-transduced HGF–collagen gel composites from a cartilage–bone matrix on implantation in immuno-
competent mice within diffusion chambers to isolate transduced from host cells. Cells (105) in 30 mL of collagen so-
lution (3 mg/mL) were injected into diffusion chambers, gelled, and sealed with nitrocellulose filter paper. The diffu-
sion chambers were implanted subcutaneously in C57BL/6 mice for 6 weeks. Tissues were harvested and processed
for histochemical analyses. (A) BMP-7-transduced HGF implant, (B) nontransduced HGF implant, (C) nontransduced
neonatal mouse calvarial cell implant, (D) BMP-7-transduced HGF implant stained with von Kossa. Original magnifi-
cation: 3100.
absorbed to solid porous scaffolds. However, the most gentle manipulation may result in loss of cells from
the scaffold. Therefore it may be useful to retain cells within porous, presized scaffolds by first resuspending
the cells in an appropriate hydrogel for subsequent loading of the scaffold. Such a method could serve to
better retain the cells within the scaffold than if the cells are suspended in a nongelling liquid. Therefore,
in these studies, we have tested two strategies for implanting genetically modified fibroblasts. Ex vivo-
transduced cells suspended in the thermoset hydrogel polymers were directly injected in vivo (Fig. 1) or the
hydrogel–cell suspensions were absorbed to preformed porous sponges before surgical implantation (Fig.
4). This approach was utilized in the segmental defect assay, as we anticipated that the hydrogel would not
gel quickly enough to form a gelled mass within the segmental defect. Bone formed in both cases, sug-
gesting these delivery modes for BMP-transduced fibroblasts could be useful for localized skeletal regen-
eration. In the latter case sponges were easily manipulated and placed into the femoral segmental defect
without losing absorbed cells. This finding suggests that hydrogel-suspended BMP-transduced fibroblasts
could be loaded into porous, custom-designed solid scaffolds before implantation into specific bony sites.27
It may not be necessary for the transduced fibroblasts to attach directly to the solid scaffold, providing more
latitude in the choice of materials for scaffold construction. However, we have tested only a single solid
scaffold (gelatin sponge)–hydrogel (collagen) combination to date. Cells suspended in thermoset hydrogels
could be useful in spinal fusion, the restoration of digits, or complex craniofacial structures that may pose
anatomical and structural limitations on the implantation of preformed materials.
In our current study, substantial skeletal repair was produced by only 104 BMP-7-transduced fibroblasts.
Femoral defects contained bone and cartilage that filled the gap after 6 weeks (Fig. 4). Given that more
cells produced larger ossicles in the ectopic assay (Table 1), it is likely that more cells would similarly pro-
duce a more robust orthotopic response. These data reveal the strong potential for bone regeneration with
as few as 104 ex vivo BMP-7-transduced, readily available autologous fibroblasts. On the basis of our data
(Table 1), it is unlikely that fewer cells will be effective in segmental defects. Other limiting factors af-
fecting the amount of orthotopic bone formed by implantation of transduced fibroblasts have not been fur-
ther studied.
Most current evidence suggests that reparative cells are recruited from the local tissue (reviewed by
Prokop17). It is therefore likely that cells capable of responding to BMP to initiate bone formation are lo-
cal. Our hypothesis is that BMP-responsive cells may be propagated from skin and gingiva ex vivo and
stimulated to form predetermined amounts of bone on implantation in vivo. In support of this hypothesis
we have demonstrated that low-passage human fibroblast strains (from different individual donors) express
BMP receptor transcripts in vitro.28 HGFs transduced with BMP-7 or cotransduced with BMP-7 and lacZ
are found within the developing cartilaginous matrix (Fig. 5), suggesting that the ex vivo BMP-7-transduced
cells directly produce bone via an endochondral-like developmental process and that BMP-7 secretion plays
a role in cartilage development. Furthermore, BMP-7-transduced HGF–collagen composites, gelled in dif-
fusion chambers and implanted in isolation from direct contact with host tissue, also produce a mineraliz-
ing bonelike matrix in vivo (Fig. 6). Such diffusion chamber experiments have been used extensively to de-
termine or confirm the osteoblastic nature of cultured cells.29–31 Others have demonstrated bone formation
by BMP-transduced fibroblasts.32 In addition, the BMP secreted by the implanted transduced cells induces
adjacent host cells to form bone.14 Taken together, our data reveal that autocrine/intracrine as well as the
well-established paracrine modes of signaling operate to form bone on implantation of ex vivo BMP-
transduced fibroblasts in vivo. These data support the findings of others, who report an autocrine mode of
action for BMP33 but do not distinguish between autocrine or intracrine modes.
Our experiments (Figs. 5 and 6) also demonstrate that BMP-7 transduction of fibroblasts alters the phe-
notype from fibroblastic to osteoblastic. Consistent with our results, fibroblastic cell lines in culture are
known to differentiate to osteoblasts after treatment with exogenous recombinant BMP.34 Furthermore, bone
marrow and other adult mesenchymally derived tissues possess multipotential cells capable of differentiat-
ing along several different pathways, resulting in distinct mesenchymal tissues.35–37 Moreover, several stud-
ies indicate that adult tissues contain cells capable of differentiating into cells typical of mature tissues de-
rived from a different cell lineage, for example, bone marrow (mesoderm) to neurons (ectoderm).38,39 We
have no evidence suggesting that the populations of fibroblasts used in these experiments contain stem cells.
It is possible that the fibroblastic cells propagated ex vivo and utilized in these experiments are descendents
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of the cells that respond to exogenous BMP signals in vivo. However, the cells responsive to these exoge-
nous BMP signals have not been identified. It is likely that transduction with BMP-7 alters the transcrip-
tional program and hence the functional phenotype of the transduced fibroblasts.
Ex vivo gene therapy for localized skeletal regeneration, in which the induction of bone formation is by
donor cells as well as host cells, could represent a distinct clinical advantage over recombinant protein21 or
in vivo gene therapy.19,40 Both of these approaches require the migration of sufficient numbers of respon-
sive host cells into the lesion. This lengthy process may not readily occur in relatively acellular lesions. In
addition, the use of cells, such as dermal or gingival fibroblasts, derived from readily accessible, quickly
healing tissues, would be associated with less donor-site morbidity than autologous bony transplants or bone
marrow-derived cell therapy. However, a variety of clinical conditions requiring bone regeneration or au-
tologous grafting exist. Further experiments are needed to determine the appropriate and most robust mode
of therapy for each.
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